健康去哪儿
健趣网登录 关闭
还没有账号?立即注册

Acute Health Effects of Ozone Exposure

赞助:
合作者:
信息的提供 (责任方):
Haidong Kan,Fudan University
September 30, 2018
October 5, 2018
October 5, 2018
October 1, 2018
December 3, 2018   (主要结果测量的最终数据收集日期)
Changes of FEV1[ Time Frame: FEV1 will be examined immediately prior to exposure, immediately after exposure, 2 hours after exposure and again the next morning ]
Changes of forced expiratory volume in 1 second

Changes of FVC[ Time Frame: FVC will be examined immediately prior to exposure, immediately after exposure, 2 hours after exposure and again the next morning ]
Changes of forced vital capacity

与当前相同
  • [ Time Frame: ]
 
Acute Health Effects of Ozone Exposure
Acute Health Effects of Ozone Exposure in Healthy Young Adults: a Randomized Controlled Study

This is a randomized controlled human exposure crossover study. We aim to investigate the acute health effects of ozone exposure in healthy young adults.

The investigators will conduct a randomized controlled human exposure crossover study among 32 healthy young adults in Shanghai, China. Each subject will be exposed twice: once to clean air and once to 200 ppb ozone in a chamber for 2 hours. During the 2-hour exposure, each subject will be requested to alternate 15 minutes of rest and 15 minutes of exercise on a treadmill. The exercise workload will be adjusted to achieve the targeted ventilation of 20±1 L/min/m2 body surface area. Ozone will be generated by a silent electric discharge method (HTU-500, AZCO Industries Ltd., Canada) and introduced into the chamber. The temperature and relative humidity in the chamber will be maintained at 22±1℃ and 50%±5%, respectively. Health examinations will be conducted immediately prior to exposure, immediately after exposure, 2 hours after exposure and again the next morning.
Interventional
N/A
分配: Randomized
干预模型: Crossover Assignment
干预模型描述:
盲法: Interventional
盲法描述:
主要目的: Basic Science
  • Other: 200 ppb ozone group
    The exposure group will be exposed to 200 ppb ozone in a chamber for 2 hours while alternating 15-min rest and 15-min exercise periods. The exercise workload will be adjusted to achieve the targeted ventilation of 20±1 L/min/m2 body surface area. The temperature and relative humidity in the chamber will be maintained at 22±1℃ and 50%±5%, respectively.
  • Other: 0 ppb ozone group
    The control group will be exposed to 0 ppb ozone in a chamber for 2 hours while alternating 15-min rest and 15-min exercise periods. The exercise workload will be adjusted to achieve the targeted ventilation of 20±1 L/min/m2 body surface area. The temperature and relative humidity in the chamber will be maintained at 22±1℃ and 50%±5%, respectively.
  • Experimental: Exposure group
    Subjects in exposure group will be exposed to 200 ppb ozone for 2 hours in a chamber.
  • Sham Comparator: Control group
    Subjects in control group will be exposed to 0 ppb ozone (clean air) for 2 hours in a chamber.
 
Recruiting
32
与当前相同
June 30, 2019
December 3, 2018   (主要结果测量的最终数据收集日期)
Inclusion Criteria: - Living in Shanghai during study period; - Ability to complete the exercise to achieve the ventilation of 20±1 L/min/m2 body surface area; - Body mass index >18.5 and ≤30 (30 is the lower limit for class 2 obesity for Chinese). Exclusion Criteria: - Smoking and alcohol abuse; - Current drug and dietary supplements intake; - Subjects with allergic diseases, such as allergic rhinitis, allergic asthma, and atopy; - Subjects with cardiovascular diseases, such as congenital heart disease, pulmonary heart disease, and hypertension; - Subjects with respiratory diseases, such as asthma, chronic bronchitis, and chronic obstructive pulmonary disease; - Subjects with chronic diseases, such as diabetes, chronic hepatitis, and kidney disease; - Subjects who have a history of major surgery; - Abnormal spirometry (FEV1 and FVC ≤ 75% of predicted and FEV1/FVC ≤ 0.65); - Abnormal baseline 12-lead resting electrocardiogram; - Abnormal blood index, such as cell counting, blood lipids, and glutamic-pyruvic transaminase (GPT).
参与研究的性别: All
最小年龄:18 Years ,最大年龄:30 Years  
没有
China
 
研究美国FDA监管的药品: No
研究涉及美国FDA监管的设备产品: No
计划分享 IPD: Undecided
Haidong Kan,Fudan University
Fudan University
Principal Investigator: Haidong Kan, Ph.D Department of Environmental Health, School of Public Health, Fudan University
Fudan University
October 2018

ICMJE     国际医学期刊编辑委员会和 世界卫生组织 ICTRP 要求的元素
请使用微信扫码报名